INTRODUCTION
Squamous cell carcinomas are very common malignant tumors in humans, occurring in organs, such as skin, oral mucosa and upper digestive tract, lung, and urogenital apparatus. Analysis of these tumors led, more than 60 years ago, to the concept of field cancerization, based on the frequent tumor multiplicity and associated changes of both epithelial and mesenchymal tissues beyond the neoplastic area (Slaughter et al., 1953) . Genetic and epigenetic changes of the epithelium have been implicated as likely primary determinants of the field cancerization process (Chai and Brown, 2009) , whereas alterations of the underlying mesenchyme have received relatively little attention. The reasons for stromal alterations, including widespread atrophic changes (Slaughter et al., 1953) , are also not understood.
Notch signaling is a form of cell-cell communication with a key role in development and tissue homeostasis (Artavanis- Tsakonas et al., 1999) . The mammalian Notch gene family codes for four closely related transmembrane receptors, whose activation depends on similar mechanisms of ligand binding, proteolytic cleavage and nuclear translocation (Kopan and Ilagan, 2009 ). The activated Notch intracellular domain associates with the DNA binding protein CSL (CBF-1 in human and RBP-Jk in mouse) converting it from a repressor into an activator of transcription (Kopan and Ilagan, 2009) . Whereas Notch-independent functions of CSL have also been reported, loss-of-function experiments have indicated that, in most mammalian systems, CSL functions mainly as a Notch effector (Kopan and Ilagan, 2009) .
The biological function of Notch/CSL is highly context dependent. In the skin, this pathway plays a well-established function in keratinocyte differentiation and tumor suppression through both intracellular and paracrine growth control mechanisms (Demehri et al., 2009; Dotto, 2008; Restivo et al., 2011; Watt et al., 2008; Williams et al., 2011) . By contrast, the role of this pathway in the mesenchymal compartment of the skin has been explored to a very limited extent. We show here that mesenchymal loss of the CSL/RBP-Jk gene is sufficient to induce in the skin several features associated with field cancerization, which are amenable to increased AP1 levels and activity. These findings are of likely clinical significance, as suppression of Notch/CSL signaling and associated gene expression events occur in stromal fields adjacent to cutaneous premalignant actinic keratosis lesions and can be induced by UVA exposure, a major cause of skin chronic and cancer-predisposing alterations. (E) Histology of skin tumors in mice at 6 months of age. Higher magnification analysis showed loss of epidermal architecture, pronounced cellular atypia, and inflammatory infiltration ( Figure S1B ). Lesions with similar characteristics were found in 7 of 7 mice that survived until this age. Tumors were classified as well to moderately differentiated SCCs (Grade I-II).
(F) Immunohistochemical analysis with anti-Pankeratin antibodies showing invading epithelial islands and tumor front in a 6-month-old mouse. Quantification of results is provided in Figure S1C .
RESULTS

Spontaneous Multifocal Keratinocyte Tumors in Mice with Mesenchymal CSL/RBP-Jk Deletion
We recently reported that maintenance of the hair follicle keratinocyte cell fate is compromised in mice with mesenchymal deletion of the CSL/RBP-Jk gene (ColI-Cre x RBP-Jk loxP/loxP ) because of intrinsically defective dermal papilla cells (Hu et al., 2010) . These same mice, by 2-4 months after birth, spontaneously developed multiple keratinocyte tumors histologically resembling squamous cell carcinoma (SCC) precursor lesions of the actinic keratosis/Bowen's disease type (Figures 1A-1D ; Figure S1A available online). These lesions were characterized by irregular architecture/expansion of the epidermis, acanthosis, dyskeratosis, and several features of incipient malignant disease, including discontinued laminin basement membrane deposition, coexpression of epithelial and mesenchymal markers, and microinvasion (Figures 1A and 1B and data not shown). Tumor stroma alterations included expression of cancer-associated fibroblast (CAF) markers (S100A4, alpha Smooth Muscle Actin) and cancer-associated matrix proteins (Tenascin C, Periostin) with a gradient of expression (Figures S1A and S1D). Increased matrix metalloprotease levels and inflammatory infiltrates were also observed (data not shown).
In 6-month-old mice, tumors exhibited features of malignant SCCs, with aberrant keratinization, pronounced dysplasia and inflammatory infiltration, and invasion of epithelial islands or spindle-shaped cells into dermis and connective tissue ( Figures  1E, 1F , S1B, and S1C). Tumors could be successfully transplanted (data not shown). DNA analysis of dissociated tumor cells separated from surrounding stroma showed neither the deletion of the RBP-Jk gene nor mutations in the p53 and Ha-, Ki-, and N-ras genes (Figures S1D and S1E and data not shown). Comparative genomic hybridization (CGH) revealed small chromosomal aberrations in all examined tumors ( Figure 1G and Table S1A ). Chromosomal alterations in tumors from the same mice were only partially overlapping, pointing to multifocal origin or separate clonal evolution, whereas specific chromosomal regions were similarly affected in tumors from different mice ( Figure 1G and Table S1A ). These regions and/or their human equivalents have been implicated in cancer development, most frequently epithelial, like murine 7qC (human 15q11.2) and 8qA1.3 (Table  S2) . qPCR confirmed alterations of these regions in the CGHanalyzed tumors and/or tumors from additional mice ( Figure 1H and Table S1B ).
For insights into gene expression, we used laser capture microdissection (LCM) of spontaneously occurring tumors in parallel with normal epidermis from the same mice. Expression of ATF3, an AP1-related transcription factor with a positive role in keratinocyte tumorigenesis (Wu et al., 2010) , was increased in all LCM-dissected tumors ( Figure 1I ), whereas growthinhibitory genes, like TGF-b family members p15
Ink4b , p16
Ink4a
, p21 WAF1/Cip1 , and Notch1, were downmodulated ( Figure 1J ).
Among positive growth regulatory genes, c-Myc, cyclin D1, CDK4, CDK6, E2F1, p63-related, and Wnt-related genes were not upregulated or even decreased, and, consistent with the complex role of NF-kB signaling in keratinocytes (Hinata et al., 2003) , members of this family were differentially modulated ( Figure S1F ).
Early Skin Changes in Mice with
Mesenchymal CSL/RBP-Jk Deletion Stromal atrophy was linked with field cancerization in the initial clinical report (Slaughter et al., 1953) . Decreased dermal thickness and reduced elastic fibers and collagen content were found in skin of mutant mice at birth, when hair follicle are still normal (Hu et al., 2010) (Figures 2A-2C , S2A, and S2B) and at 3 weeks of age, in regions of conserved hair follicle structure and density and when both mutant and control mice had entered the telogen phase of the hair cycle (Figures 2A, S2A , and S2C). Collagen I and Elastin mRNA expression was unaffected (data not shown), whereas Collagen I protein levels were reduced in skin of mutant mice, with increased ratio of soluble versus insoluble forms ( Figure 2D ). Consistent with a proteolytic mechanism, mutant mice had elevated dermal MMP activity already at birth (Figure 2E ). Expression of a CAF marker, Periostin, but not Tenascin C, was also increased in these mice at this time ( Figure S2D and data not shown). Dermal fibroblasts density and proliferative index were similar to controls, with lower apoptosis ( Figures  S2E-S2G ). BrdU labeling indicated that proliferation of interfollicular keratinocytes was already increased in postnatal day (P) 0 mutant mice ( Figure 2F ). This was accompanied by increase of phosphorylated activated form of Fibroblast Growth Factor Receptor 1, which occurred already in mutant embryonic day (E) 16.5-18.5 embryos (Figures 2G and 2H) together with augmented expression of mitogenic FGFs by underlying dermal fibroblasts (shown (G) Summary of CGH DNA analysis of skin tumors versus unrelated normal tissue (brain) from the same mice. For each tumor are listed specific chromosomal regions that were duplicated (+), deleted (À), or, for pairs of tumors derived from the same mouse, unaffected (N). Raw CGH data and statistical significance are provided in Table S1A . Statistical permutation tests showed that the repeated identification of four overlapping rearrangements in five mice (as found, for instance, for 7qC and 8qA) is highly significant (p = 0.0005). (H) (Upper) Map of mouse chromosomal 7qC region and overlapping segments of duplication (green bars) in the indicated multiple tumors. Maps of other chromosomal regions with overlapping alterations in multiple tumors are provided in Table S1A . (Lower) qPCR analysis of tumor and normal DNA samples utilized for CGH was performed with primers for three sites within the 7qC region (indicated by arrows in the previous panel). Results are in arbitrary units after internal normalization for an unrelated chromosomal region (15qB3.1). Similar results were obtained after normalization for two other chromosomal regions (5qC1 and 13qB1; data not shown). Further qPCR analysis showed duplications of the 7qC and 8qA regions in four and five additional tumors, respectively, out of six that were analyzed, from three more mice (See additional data in Table S1B ). (I and J) qRT-PCR analysis of LCM samples from tumors versus flanking normal epidermis (identified by double immunofluorescence with anti-K14 and antiTenascin C antibodies, as shown in Figure S1D ) from two mice, two tumors per mouse. Expression of indicated genes is in arbitrary units utilizing b-Actin for normalization. Analysis of other genes is in Figure S1F . *p < 0.01 by one-way ANOVA followed by Bonferroni's test. Scale bars: 200 mm for (B) and (D) ; 40 mm for (C) and (E) . Error bars represent standard deviation (SD) of the mean. Figure S2A ) was quantified in five RBP-Jk mutant mice and five controls (black and white bars) at 4 days and 3 weeks of age (*p < 0.01). Histological images are in Figure S2A below). Loricrin, a differentiation marker important for skin barrier function, was downmodulated in mutant E16.5-E18.5 embryos and P0 mice ( Figure 2I ), with increased transepidermal water loss (TEWL) at birth that normalized in later days ( Figure S2H ). LCM, followed by qRT-PCR, showed loss of RBP-Jk expression in mutant embryos dermis, with no decrease in epidermis ( Figure S2I ). Parallel qRT-PCR analysis confirmed decreased Loricrin expression in epidermis of mutant embryos and P0 mice, with similar downmodulation of another late differentiation marker, SPRR1a ( Figure 2J ). RT-PCR analysis showed also deregulation of many growth factors and cytokines in epidermis of mutant embryos and mice, which may contribute to their later phenotype ( Figure 2J ).
Role of Inflammation in Spontaneous Skin Tumor Development
Inflammation is an important determinant of chronic tissue alterations leading to cancer. Inflammatory cells, identified by anti-CD45 staining, became detectable in dermis of mutant mice a few days after birth, followed by localized inflammatory infiltrates and concomitant expression of Tenascin C and, in overlying epidermis, Keratin 6, a marker of epidermal hyperplasia ( Figure 2K ). Foci of inflammatory infiltrates and Tenascin C and Keratin 6 expression expanded significantly in subsequent days ( Figure 2K ), together with recruitment of macrophages (Figures 2K and 2L) . LCM of stromal tissue followed by qPCR showed similar levels of RBP-Jk gene deletion in unaffected versus focally altered areas ( Figure S2L ), pointing to the importance of more indirect events.
For wider view of skin than permitted by immunohistochemical analysis, we adopted a technique, Fluorescence Diagnosis (FD), used in the clinic for imaging of hyperplastic, premalignant, and malignant keratinocytic lesions (Krammer and Plaetzer, 2008) . FD is based on preferential uptake of 5-aminolevulinic acid (5-ALA) by hyperproliferative cells and conversion into porphyrins detectable by fluorescence excitation. Relative to littermate controls, back skin of mutant mice already exhibited stronger and widespread FD signal at birth ( Figure 3A ), consistent with increased keratinocyte proliferation detected by BrdU labeling ( Figure 2F ). Discrete regions of higher FD positivity, likely corresponding to foci of inflammatory infiltration and epidermal hyperplasia, were also found, which increased in number over time, eventually coalescing and marking areas of multifocal tumor development ( Figures 3A and 3B) .
To assess the role of inflammation, (ColI-Cre x RBP-Jk loxP/loxP ) mice were treated with Celebrex, a broad anti-inflammatory agent and COX-2 inhibitor. When treatment was started at birth, strength and expansion of FD signal, as well as eventual tumor formation, were significantly counteracted, even if not totally suppressed ( Figures 3C, 3D , and S3A). By contrast, no such effects were observed when the treatment was initiated after tumor development ( Figure S3B ), consistent with the chromosomal alterations that have occurred by this time and findings that suppression of inflammation can prevent but not reverse tumorigenesis (Colotta et al., 2009 ).
Tumor-Enhancing Mechanisms of CSL-Deficient Dermal Fibroblasts
Full-thickness grafting of skin of mice with the mesenchymal CSL/RBP-Jk deletion onto immuno-compromised animals resulted in similar epidermal hyperproliferation and underlying dermal alterations, such as increased Tenascin C and MMP3 expression and decreased elastic fibers and collagen content. With time, the grafts gave rise to tumors similar to those of the original mice (data not shown).
To assess whether dermal fibroblasts with CSL/RBP-Jk deletion were intrinsically endowed with tumor-promoting capability, they were admixed with weakly tumorigenic mouse (Pam212) (Roop et al., 1983) or human (SCC13) (Rheinwald and Beckett, 1981) keratinocyte lines, followed by injection into immunecompromised mice at the dermal-epidermal junction, that is, a location approximating that of malignant skin tumor formation (Wu et al., 2010) . Tumors formed in the presence of RBP-Jk À/À fibroblasts were significantly larger than controls ( Figure 4A ), with increased proliferation ( Figure 4B ) and cellularity ( Figure 4C ) and decreased differentiation ( Figure 4D ). There was disruption (C) Masson-trichrome staining of total collagen in P4 mouse skin (blue) with Nuclear Fast Red for counterstaining. Images are representative of four mice per genotype. Collagen I and III immunostaining is in Figure S2B . (D) Biochemical quantification of total collagen and ratio of soluble versus insoluble fractions in 3-week-old mice. Five mice per genotype were analyzed. *p < 0.01. (E) In situ zymography of P4 mouse skin with MMP3 and MMP13 preferential substrates. Little signal was observed in presence of MMP inhibitor GM6001 (data not shown). MMP activity in epidermis and hair follicles is likely due to diffusion, consistent with MMP3 and MMP13 mRNA levels being increased selectively in fibroblast compartment of RBP-Jk mutant mice ( Figure S4A and data not shown). Increased MMP3 and MMP13 protein expression in skin of mutant mice was also observed by immunohistochemistry (data not shown). (F) P0 mice were injected with BrdU, followed by BrdU labeling determination in interfollicular epidermis. Four mice per genotype were analyzed (*p < 0.01). of Laminin basement membrane deposition ( Figure 4E ), loss of E-Cadherin ( Figure 4F ), and increased MMP3 production in surrounding matrix ( Figure 4G ).
An important question was whether fibroblasts with RBP-Jk deficiency can also impact on normal keratinocytes prior to transformation. Intradermal injection of human primary keratinocytes (HKCs) in combination with control fibroblasts gave rise to large epidermal islands with tightly adherent layers of keratinocytes and pronounced granular layer differentiation ( Figure 4H ). By contrast, HKCs admixed with RBP-Jk À/À fibroblasts gave rise to islands with loosely connected keratinocytes and signs of cellular atypia ( Figure 4H ), higher BrdU labeling index ( Figure 4I ), and decreased expression of ''early'' differentiation markers like Keratin 1 ( Figure 4J ). Basement membrane laminin deposition was uneven ( Figure 4K ), with increased Tenascin C and Periostin expression in surrounding stroma (Figures 4L and 4M) .
To probe into underlying mechanisms, freshly isolated fibroblasts from P0 mice with and without RBP-Jk deletion were analyzed for expression of growth factors/cytokines, matrix components, and remodeling enzymes. Growth factor genes, such as FGF7 and 10, Igf2, and CSF-1, which promote keratinocyte proliferation and/or inflammation (Wagner et al., 2010; Werner et al., 2007) , were upregulated in several independent preparations of RBP-Jk À/À fibroblasts versus controls (Figure S4A) . Matrix metallo-proteases (MMP2, 3, 9, and 13) and Tenascin C and Periostin were similarly upregulated ( Figure S4A ). Expression of alpha Smooth Muscle Actin (ACTA2) and PDFG Receptor a isoform (PDGFRa) was also enhanced, whereas that of other CAF markers, like PDGFRb, FAP, S100A4 and Desmin, were not affected or even decreased ( Figure S4A and data not shown). Similar modulation of gene expression was observed with cultured dermal fibroblasts from RBPJk À/À mice and fibroblasts with the ''floxed'' RBP-Jk gene after ''acute'' deletion by a Cre-expressing adenovirus ( Figures S4B  and S4C ). Dermal fibroblasts express both Notch 1 and 2 receptors. siRNA-mediated knockdown of Notch1 and, to a greater extent, Notch2 resulted in suppression of the canonical Hes1 target gene and concomitant upregulation of genes induced by the RBP-Jk deletion ( Figure S4D) .
For further insights, we resorted to cDNA microarray analysis of dermal fibroblasts from P0 mice plus/minus RBP-Jk deletion in parallel with cultured dermal fibroblasts plus/minus deletion of the ''floxed'' RBP-Jk gene by Ad-Cre. As a consequence of RBP-Jk deletion, 381 genes were found similarly modulated. Among significant biological processes to which upregulated genes could be assigned were ''DNA damage and Stress Response,'' ''tissue remodeling and wound repair,'' ''vasodilation,'' and ''inflammatory response'' ( Figure S4E ). c-Jun/AP1 was a prominent transcription factor in the network that could be built from the validated set of genes deregulated by RBP-Jk deletion ( Figure S4F ). Involvement of various AP1 family members was assessed further below. Other relevant genes included mediators of cell-matrix and cell-cell interactions (CD44, Syndecan-1 (SDC1), Hyaluronan synthase 2 (HAS2) and Hyaluronan-mediated motility receptor (HMMR)), kinases (MAP2K3, MAPK6, MAPK14, Prkar2a) and trascription factors (Ets1 and NFATc3) involved in stress and/or growth responses, and determinants of inflammation (COX2, CSF-1, IL17RA). Increased expression of these genes, as well as of FGF7 and FGF10, was confirmed by LCM and qRT-PCR of dermis from P0 mutant versus wild-type mice, and E16.5 and E18.5 embryos ( Figure S4G ). Mesenchymal loss of the PTEN gene was reported to enhance mammary tumor development driven by transgenic oncogene expression, with induction of a CAF phenotype that overlaps only partially with the one caused by RBP-Jk deletion (Trimboli et al., 2009) . Given previous work linking Notch signaling to control of PTEN expression (Demarest et al., 2008) , we examined expression of this gene but found similar levels in mutant fibroblasts and controls ( Figures S4A and S4B) .
A common feature of many genes upregulated in RBP-Jk À/À fibroblasts is that they are under positive AP1 control. Notch/ RBP-Jk signaling can function as a negative regulator of AP1 activity, also through modulation of various AP1 family members (Chu et al., 2002; Talora et al., 2002) . Consistent with these previous findings, expression of several AP1 family members was upregulated in dermal fibroblasts from mutant mice and embryos ( Figures 5A-5C , S4G, S5A, and S5B) and fibroblasts with Notch1 and Notch2 knockdown ( Figure S4D ).
To assess which AP1 family members are more functionally important, we evaluated the consequences of their knockeddown expression in RBP-Jk À/À fibroblasts. Downmodulation of c-Jun or c-Fos returned expression of all tested growth factors, cytokines, matrix components, and MMPs to levels close to control cells ( Figures 5D, S5C, and S5D) . Knockdown of other AP1 family members could counteract upregulation of MMP3 expression, whereas it had more limited effects on other genes like Fgf7 and CSF-1 ( Figure S5E ).
To assess the in vivo significance of these findings, RBPJk À/À fibroblasts transfected with anti-c-Jun siRNAs versus scrambled controls were admixed with SCC13 cells, followed by intradermal injection into mice. Tumors formed in the presence of RBP-Jk À/À fibroblasts with c-Jun knockdown had lower weight, with pronounced apoptosis/necrosis of cells in central areas and reduced proliferation, and enhanced differentiation of cells at the periphery ( Figures 5E-5H and S5F-S5I). Differences in tumor formation were accompanied by decreased expression of CAF markers in surrounding stroma together with decreased MMP expression and activity ( Figures 5I and 5J and data not shown).
Relevance to Human Skin
An important question was whether downmodulation of CSL signaling can lead to a CAF-like phenotype in human cells. shRNA-mediated knockdown of CSL (RBP-Jk) in two independent strains of human primary dermal fibroblasts resulted in reduced expression of the ''canonical'' Notch targets Hes1 and Hes5, as well as of Notch1 and 2 receptors, and Notch ligands Jagged 1 and 2 ( Figures 6A and S6A) . Expression of c-Jun and c-Fos, and many other genes upregulated in mouse RBPJk À/À cells, was similarly affected in human dermal fibroblasts with CSL knockdown (Figures 6A, S6A, and S6B) . As in xenografts with mouse fibroblasts, SCC13 cells admixed with human dermal fibroblasts with CSL knockdown formed tumors of greater size and cellularity and more disordered differentiation than the controls, with upregulation of Tenascin C and Periostin expression in surrounding stroma ( Figures 6B-6D and S6C and data not shown).
To assess the relevance of the above findings to the clinical situation, we used LCM of surgically excised skin samples from patients with lesions preceding SCC formation. Analysis of stroma underlying areas of premalignant lesions (actinic keratosis, AK) along with skin fields farther away, revealed consistent inverse relation between expression of Notch receptors, Hes1 and Hes5 versus c-Jun, c-Fos and other genes under negative Notch/CSL control, like CAF markers, CD44 and COX-2, in the lesion-underlying stroma ( Figure 7A ). The LCM and qRT-PCR results were further validated by immunofluorescence analysis of excised skin regions, showing decreased Notch2 signal intensity with concomitant upregulation of c-Jun in the Vimentin-positive cells of the AK-underlying stroma versus flanking skin ( Figures 7B and S7A-S7C) .
UV light exposure is a major etiopathological agent of premalignant and malignant skin cancer formation (Rittié and Fisher, 2002) . Whereas UVB has limited penetration power and its effects are mostly limited to epidermal cells, UVA can also directly affect cells of underlying dermis. UVA-but not UVBirradiation of human skin explants followed by LCM of upper dermal compartment and qRT-PCR showed significant downmodulation of Notch1, Notch2, and Hes1 genes even at lowest doses, whereas c-Jun expression was upregulated ( Figure 7C and data not shown). In time-course experiments, modulation of these genes occurred as early as 1 hr after UVA exposure and persisted for up to 5 days ( Figures 7C and S7D-S7F) .
For further insights, we focused on the Notch2 gene. As with skin explants, downmodulation of this gene, and upregulation of c-Jun, occurred in three independent strains of cultured human dermal fibroblasts, within 20 0 of UVA exposure, persisting up to 5 days ( Figure S7G and data not shown). Nascent Notch2 transcripts, detected by qRT-PCR of the first exon-intron junction, were also downregulated at late times of UVA exposure as mature transcripts ( Figure S7G ). Persistent downmodulation would be consistent with a permanent modification of the Notch2 transcription locus. In fact, PCR analysis of methylation-enriched DNA samples from dermal compartment of skin explants and cultured dermal fibroblasts indicated that the GCrich region of the Notch2 promoter was increasingly methylated as a function of time after UVA exposure, with no increased methylation of a distal GC-rich region of the same gene ( Figures 7D (G) Mice as in (E) and (F) were BrdU labeled for 2 hr prior to sacrifice. BrdU labeling of tumor keratinocytes (identified by Keratin 14 staining) admixed with RBP-Jk deficient fibroblasts plus/minus c-Jun knockdown (black and white bars, respectively) was determined in parallel with tumor weight (*p < 0.01). (H-J) Same samples were analyzed by immunostaining for Keratin 1 (H) and Tenascin C (I) and in situ zymography with a preferential MMP13 substrate (J). Asterisks indicate the epithelial tumor compartment. Scale bars: 20 mm for (C), (E), (F) (right two panels), and (H)-(J); 200 mm for (F) (left two panels). Error bars represent SD of the mean. and S7H). Importantly, similar differences in methylation of the Notch2 promoter were found in the clinical situation, in stroma underlying AK lesions versus skin fields further away ( Figure 7E ).
DISCUSSION
Field cancerization is a clinical condition of major significance for cancer recurrence and lethality, which is still poorly understood (Chai and Brown, 2009 ). It can develop at various body sites, among which the skin is the most common. Development of mouse genetic models to probe into underlying molecular defects would be highly desirable. The skin phenotype of mice with mesenchymal RBP-Jk deletion presents several features that are reminiscent of those found in field cancerization. The clinical process is associated with a ''diagnostic triad'' of multifocal tumors, expanding alterations of the surrounding epithelium and atrophic changes of the underlying stroma (Slaughter et al., 1953) . Among these, the stromal atrophy of RBP-Jk mutant mice is a feature that has not yet been observed, to our knowledge, in any other mouse cancer model. The similarity to the clinical situation of expanding multifocal lesions detected by the fluorescence diagnosis technique is also remarkable.
The earliest biochemical alterations resulting from RBP-Jk deletion in dermal fibroblasts include increased expression of genes with mitogenic and/or proinflammatory function in both fibroblasts and overlying keratinocytes. These in turn can elicit further changes, most notably an inflammatory reaction, both directly and through transiently compromised skin barrier function. Recruitment of inflammatory cells is followed by localized infiltrates, possibly by an initially weak (and stochastic) signal, which is then amplified by an immunological cascade. Locally increased inflammation is likely to be a determining factor of other focal changes in dermis and overlying epidermal tissue. Inflammation is also known to increase chromosomal instability (Colotta et al., 2009 ) and could thus contribute to later multifocal tumors, which we found associated with specific chromosomal alterations. Treatment of RBP-Jk mutant mice with a COX-2 inhibitor as anti-inflammatory agent delayed formation of focal lesions and tumors, raising the exciting prospect that, even in patients with field cancerization, inhibition of inflammation, even if not sufficient to reverse tumorigenesis, could be used to prevent or retard secondary tumor development. In line with this possibility is our other finding that COX-2 expression is upregulated in both mouse and human fibroblasts by loss of CSL/RBP-Jk function and in the clinical situation, in stroma underlying actinic keratosis lesions versus skin fields further away.
Similar changes in gene expression were elicited by loss or downmodulation of the CSL gene and knockdown of Notch1 and Notch2. These included upregulated expression of several AP1 family members. Consistent with their shared key role (Eferl and Wagner, 2003) , downmodulation of c-Jun or c-Fos had the most significant effects in RBP-Jk deficient fibroblasts, reverting expression of all tested deregulated genes. Even in vivo, the tumor-enhancing effects of RBP-Jk À/À fibroblasts were counteracted by the c-Jun knockdown. Importantly, an inverse relationship between Notch/CSL activity and cJun/c-Fos expression was also found in excised skin samples from enrolled patients with cutaneous field cancerization, in stromal fields underlying actinic keratosis versus distant normal epidermis.
Basal level of Notch activity in dermal cells (as also observed by use of a reporter mouse; our unpublished observations) can be explained by concomitant expression of Notch receptors and ligands by the same or neighboring cells. In the present context, we were concerned with exogenous signals that cause downregulation of this pathway. Cutaneous field cancerization usually develops in sun-exposed areas in elderly people or immunosuppressed patients and is defined by the appearance of multiple actinic keratosis lesions on damaged skin. UVA light exposure can directly affect the dermis, and its importance in UV-induced carcinogenesis is increasingly recognized (Ridley et al., 2009) . We have found that UVA, but not UVB, exposure has a rapid, negative impact on expression of Notch receptors and downstream targets in the dermis of human skin explants and dermal fibroblasts, in parallel with c-Jun and c-Fos upregulation. This is in contrast to the consequences of UVB exposure of human epidermis and keratinocytes, which elicits a p53-dependent upregulation of Notch1 expression as a prosurvival and prodifferentiation reaction Yugawa et al., 2007) .
A very early consequence of UVA exposure is production of radical oxygen species (ROS) with consequent ligand-independent activation of EGFR/ERK/AP1 signaling (Rittié and Fisher, 2002) . Whereas increased ERK/AP1 activity can negatively regulate Notch1 expression and activity (Kolev et al., 2008) , downmodulation of Notch signaling enhances AP1 activity. Thus, a negative feedback loop between the two pathways can be involved in the initial impact of UVA exposure on gene expression. A concomitant attractive mechanism is provided by epigenetic modifications, which we have found to occur shortly after UVA exposure at level of the Notch2 promoter. This is consistent with recent findings of a recruitment of DNA methyltransferase I (DNMT1) and methylation of selective GCrich promoters in rapid response to increased ROS levels (O'Hagan et al., 2011) . DNA methylation of the Notch2 promoter could account for sustained downmodulation of the gene and be of considerable clinical significance, as we found that the Notch2 promoter is also differentially methylated in vivo, in actinic keratosis underlying stroma versus skin fields further away. DNA methyl transferase inhibitors are already approved for clinical trials of cancer treatment (Baylin and Jones, 2011) and an exciting possibility is that these compounds can also be employed for preventing and/or reversing stromal alterations associated with field cancerization.
EXPERIMENTAL PROCEDURES
Mice and Human Samples Development of mice with mesenchymal RBP-Jk deletion was previously reported (Hu et al., 2010) . All mouse work was performed in accordance with the Swiss guidelines and regulations for the care and use of laboratory animals.
Human skin samples for primary cell preparation were obtained from abdominoplasty procedures at the Department of Plastic, Reconstructive and Aesthetic Surgery, Lausanne University Hospital (Switzerland), with patients' and institutional approvals. Samples of actinic keratosis and SCC were obtained from clinical biopsies at the Departments of Dermatology, University of Tü bingen (Germany), and Zurich University Hospital (Switzerland). Parts not needed for histological diagnosis were further processed with institutional review board approval.
Cell and Tissue Manipulations
Conditions for culturing of cells, organ explants, viral infection, and siRNA transfection were previously reported (Hu et al., 2010; Kolev et al., 2008; Wu et al., 2010) . Human dermal fibroblasts were prepared from the dermis of discarded skin samples of abdominoplasty patients. Special attention was given to remove as much as possible of adipose and deeper dermal tissues to minimize the presence of subcutaneous preadipocytes and adipocytes. Skin samples were cut into small pieces and digested using 3% Collagenase I (Sigma-Aldrich) in HBSS (Ca 2+ and Mg 2+ free), 1 gram of tissue in 2 ml enzyme solution. The mixture was incubated at 37 C for 1 hr, and enzyme activity was stopped by adding equal volume of DMEM + 10% FBS. After filtering through a 20 mm mesh, cells were collected by centrifugation (2000 rpm for 5 minutes) and plated at a concentration of 100,000 cells/10 cm dish. Attached cells were washed extensively five times with warmed PBS 1 day after plating. Cells were cultured in DMEM + 10% FBS till 60%-70% confluent before passage. For the present study, cells at passage 5 or 6 from multiple donors were used. UV irradiation of cells was at 60%-70% confluency. Full thickness grafting of mouse skin (Hu et al., 2010) and intradermal tumorigenicity assays (Wu et al., 2010) were also as described. Detailed conditions for cell culture and in vivo testing are provided in the Extended Experimental Procedures. UV exposure was performed in a Bio-Link crosslinker UV irradiation system (Vilber Lourmat, Cedex, France) equipped with exchangeable UVA (375 nm) and UVB (312 nm) lamps. The exposure dosage was measured with a portable photometer IL1400A (International Light Technologies, Peabody, MA, USA).
For more details and skin organ culture, collagen determination, LCM, and anti-inflammatory treatment, please see Extended Experimental Procedures. The list of siRNAs and shRNAs used for this study is provided in Table S3 .
qRT-PCR and cDNA Microarray Analysis, LCM, and Methylated DNA Detection Conditions for qRT-PCR, immunoblotting, and immunofluorescence and cDNA microarray analysis were as previously described (Hu et al., 2010; Nguyen et al., 2006) . The list of gene-specific primers is provided in Table  S3 . PCR arrays were from SAbiosciences (PAMM-041). LCM was performed using an Arcturus XT microdissection system (Applied Biosystems, Carlsbad, CA, USA) as before (Hu et al., 2010) . Methylated DNA was isolated using MethylCollector (Active Motif, Carlsbad, CA, USA) in accordance with the manufacturer's protocol. Recovered DNA was quantified with a Nanodrop 1000 spectrophotometer (Nanodrop) prior to qPCR analysis.
Immunodetection
Antibodies are listed in Table S3 . Immunofluorescence images were acquired with a Zeiss LSM510 meta laser scanning microscope. For quantitation of Notch2 immunofluorescence signal, digitally acquired images for each color channel were separately imported into ImageJ software and converted into binary images. The numbers of pixels (representing the intensity of the Figure 7 . Downregulation of Notch Signaling in Stromal Fields adjacent to Keratinocyte Premalignant Lesions and Impact of UVA Exposure (A) Excised skin samples from ten patients, containing, in each case, a field of normal epidermis well separated from one with actinic keratosis (AK) lesions were utilized for LCM of the AK underlying stroma versus stroma fields further away, followed by qRT-PCR analysis of indicated genes, using 36b4 for normalization. Results are expressed as heat map of fold changes of the indicated genes in AK-underlying stroma versus stroma further away. Expression of a less complete set fluorescence signal) were measured using ''Measurement'' function. For single-cell Notch2 signaling measurement, Vimentin-positive single cells were selected using ''Lasso Tool'' in Photoshop Element 8.0 software (Adobe), and the Notch2 signal were read out by histogram and calculated in Microsoft Excel 2004 software (Microsoft).
Fluorescence Diagnosis
Newborn or adult mice (with back skin shaved 24 hr before treatment) were topically applied 5-ALA mix (containing 10% 5-ALA w/w [Sigma-Aldrich, St. Louis, MO, USA] in 20% DMSO solution) at a dosage of 10 mg/cm 2 . Three hours later, mice were analyzed under a Xenogen IVIS-200 optical in vivo imaging system (Caliper Life Sciences, Mountain View, CA, USA) with excitation wavelength at 430 nm and emission wavelength at 640 nm, using a DSRed filter at 1.5 cm depth and 10 s exposure time (f2). The binning setting was 2 pixels per bin and field of view (FOV) was 24. Intensity of the emitted signal was calculated using Living Image 3.2 software (Caliper Life Sciences). For newborn animals (P0-P6), the minimum/maximum of reading was set at 3.5 3 10 6 /8 3 10 7 photons/s; for adult mice the minimum/maximum was set at 3 3 10 7 /3 3 10 8 .
Array CGH Excised skin tumors were minced into small pieces and digested in 1% Collagenase I (Sigma-Aldrich; 37 C for 1 hr) for removal of stromal tissue.
The resulting suspension was filtered through a 40 mm mesh and epithelial fragments were used for DNA extraction, using a Wizard Genomic DNA Purification Kit (Promega, Madison, WI, USA). Tumor DNA samples were labeled with Cy3 and hybridized to Nimblegen mouse CGH arrays together with Cy5-labeled normal brain DNA extracted from the same mice. Arrays contained 2.1 million probes across the whole genome based on the MM9 genome build. CGH was according to Nimblegen protocols. Scanning with an Agilent G2565BA Microarray Scanner was followed by image and data processing using Nimblescan software v.2.5.
Statistical Analysis
PRISM software (Graph Pad Software Inc.) was used to assess statistical significance of the results, employing one-way ANOVA followed by Bonferroni's test, except for RNAi experiments for Jun B, Jun D, FosB, FosL1, FosL2 , and shRNA experiments, where Dunnett's test was applied.
ACCESSION NUMBERS
Array CGH data can be accessed through the Gene Expression Omnibus (GEO) number GSE36464. Microarray data can be accessed through the GEO number GSE36359.
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